1 not yet recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Cisplatin Adverse Reaction: new trials by email Literature Review of Cisplatin Adverse Reaction trials Research Report on Cisplatin Adverse Reaction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction GMDTC 1 mg/ml, GMDTC 2mg/ml, GMDTC 3mg/ml - Cisplatin Nephrotoxicity, Cisplatin Adverse Reaction | Phase 1 | Not yet recruiting | Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. | 60 | 2026-10-01 | 2026-09-17 |
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. (1)
China (1)